Your browser doesn't support javascript.
loading
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.
Chan, David Lh; Pavlakis, Nick; Schembri, Geoffrey P; Bernard, Elizabeth J; Hsiao, Edward; Hayes, Aimee; Barnes, Tristan; Diakos, Connie; Khasraw, Mustafa; Samra, Jaswinder; Eslick, Enid; Roach, Paul J; Engel, Alexander; Clarke, Stephen J; Bailey, Dale L.
Afiliação
  • Chan DL; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Pavlakis N; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Schembri GP; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Bernard EJ; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Hsiao E; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Hayes A; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Barnes T; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Diakos C; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Khasraw M; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Samra J; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Eslick E; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Roach PJ; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Engel A; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Clarke SJ; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
  • Bailey DL; Departments of Nuclear Medicine, Medical Oncology and Surgery, Royal North Shore Hospital, Sydney Medical School and Faculty of Health Sciences, University of Sydney, and Sydney Vital Translational Cancer Research Centre, Sydney, Australia.
Theranostics ; 7(5): 1149-1158, 2017.
Article em En | MEDLINE | ID: mdl-28435454
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Somatostatina / Tumores Neuroendócrinos / Fluordesoxiglucose F18 / Gradação de Tumores / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Tipo de estudo: Evaluation_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Somatostatina / Tumores Neuroendócrinos / Fluordesoxiglucose F18 / Gradação de Tumores / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada Tipo de estudo: Evaluation_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article